LEXICON PHARMACEUTICALS, INC., 2026-02-17
An SEC Form D private-offering notice from The Woodlands, TX, a $59,150,000 filer-stated offering target in Biotech. Filed 2026-02-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Lexicon Pharmaceuticals is a publicly traded biopharmaceutical company (Nasdaq: LXRX) developing treatments for cardiometabolic disease and chronic pain, including the approved heart failure drug INPEFA.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- 100th Meridian Ventures, LLC, 2026-02-18, $3M, Amarillo, TX
- Accretion Therapeutics, Inc., 2026-02-17, $1M, Lincolnshire, IL
- Quantum Power Group, Inc., 2026-02-17, Corpus Christi, TX
- Treysta Medical Technologies Inc., 2026-02-17, $300K, Gainesille, FL
- Elevate Clinical Research, Inc., 2026-02-17, Austin, TX
- NexEos Diagnostics, Inc., 2026-02-17, $3M, Chester Springs, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.